ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 653

Dermal Injury Promotes Nephritis Flare in Lupus-Prone NZM2328 Mice

Kaitlyn Clark1, Tamra J. Reed1, Jeffrey B. Hodgin2 and J. Michelle Kahlenberg3, 1Internal Medicine, Rheumatology, University of Michigan, Ann Arbor, MI, 2Department of Pathology, University of Michigan, Ann Arbor, MI, 3Internal Medicine, Division of Rheumatology, University of Michigan, Ann Arbor, MI

Meeting: 2014 ACR/ARHP Annual Meeting

Keywords: Lupus, Mouse model, nephritis and skin

  • Tweet
  • Email
  • Print
Session Information

Title: Systemic Lupus Erythematosus - Animal Models

Session Type: Abstract Submissions (ACR)

Background/Purpose: Systemic lupus erythematosus is an autoimmune disease with pleotropic manifestations, including severe skin disease, hematologic abnormalities and nephritis.  Clinically, lupus is characterized by episodes of flare and remission, and exposures such as UV light or viral infections have been proposed as flare triggers.  However, induction of flare has been difficult to emulate in murine models. Here, we describe a system in which cutaneous injury is able to trigger the development of a lupus nephritis flare in lupus-prone mice.

Methods: 20-week old NZM2328 (NZM) female mice were depilated in a 2×4 cm area on the dorsal skin followed by 25 applications of duct tape under isofluroane anesthesia.  NZM mice lacking the type I interferon (IFN) receptor (iNZM) were used as a non-lupus prone control.  Skin biopsies were taken prior to and following tape-stripping, and gene expression changes were evaluated via quantitative PCR.  Serial blood draws and urine collection were obtained following tape stripping, and anti-double-stranded DNA titers, C3 levels and urine albumin/creatinine ratios were measured via commercially available kits.  Inflammatory cells were isolated from whole kidneys and cell populations were measured via flow cytometry.  Renal immune complex deposition was assessed via immunofluorescent staining for IgG and C3.  Renal inflammation was assessed on Hematoxylin and Eosin stained sections by a blinded renal pathologist.

Results:   NZM mice subjected to tape stripping had a rapid dermal upregulation of type I IFN-mediated and inflammatory gene expression.  Importantly, tape-stripped NZM mice developed onset of proteinuria and death within 3 weeks of skin injury whereas non-tape stripped littermates remained free of proteinuria. This was coupled with a drop in serum C3.  Proteinuria induction did not occur in tape-stripped iNZM mice, suggesting the rapid death was not secondary to skin injury itself. In NZM mice, renal immune complex deposition was enhanced within two weeks of tape stripping, as was renal expression of the B cell chemokine CXCL13.  Evaluation of renal inflammatory cell populations revealed an increased infiltrate of B cells in the kidney prior to proteinuria onset. 

Conclusion:   Cutaneous injury via tape-stripping induces a rapid flare of lupus nephritis that is preceded by enhanced renal immune complex deposition and B cell recruitment.  This novel model provides a mechanism to study the communication between the dermal and renal immune systems and how crosstalk between these systems can lead to lupus flare, thus providing potential targets for prevention of flares in human disease.


Disclosure:

K. Clark,
None;

T. J. Reed,
None;

J. B. Hodgin,
None;

J. M. Kahlenberg,
None.

  • Tweet
  • Email
  • Print

« Back to 2014 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/dermal-injury-promotes-nephritis-flare-in-lupus-prone-nzm2328-mice/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology